Pioneering Paclitaxel Delivery: Next-generation Protein Nanocarriers for Transformative Cancer Therapy

Recent Patents on Anti-Cancer Drug Discovery · Published 2026-07-21 · DOI 10.2174/0115748928469302260712091914

Authors (7)

Lalit Kumar, Neelam Sharma, Rajeev Arya, Biswajit Dash, Arijit Chaudhuri, Rakesh Kumar, Mridhula Manimaran

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Kumar, L., Sharma, N., Arya, R., et al. (2026). Pioneering Paclitaxel Delivery: Next-generation Protein Nanocarriers for Transformative Cancer Therapy. Recent Patents on Anti-Cancer Drug Discovery. https://doi.org/10.2174/0115748928469302260712091914

Related articles

• Tracing the Technological Trajectory of CAR-T Cell Therapy in Cancer Treatment through Patent Analysis · Recent Patents on Anti-Cancer Drug Discovery · 2025 · Same journal
• Resibufogenin and Oxaliplatin Synergistically Inhibit Diffuse Gastric Cancer by Inactivating the FAK/AKT/GSK3β/β-Catenin Signaling Pathway · Recent Patents on Anti-Cancer Drug Discovery · 2025 · Same journal
• Targeted Therapy with Dalpiciclib in a Pediatric Patient with Anaplastic Ependymoma: A Case Study and Literature Review · Recent Patents on Anti-Cancer Drug Discovery · 2025 · Same journal
• Selenium Supplementation in Children and Adolescents Undergoing Cancer Treatment: An Analysis of the Inflammatory Profile and theExpression of Antioxidant Regulators · Recent Patents on Anti-Cancer Drug Discovery · 2026 · Same journal
• A Comprehensive Review of Genistein and Chitosan: Mechanistic Foundations, Regulatory Roadmap, and Future Research Directions · Recent Patents on Anti-Cancer Drug Discovery · 2026 · Same journal
• Patent Landscape and Technological Trajectory of Drug Delivery Systemsfor Overcoming Drug Resistance in Non-small Cell Lung Cancer · Recent Patents on Anti-Cancer Drug Discovery · 2026 · Same journal
• Aucubin Inhibits Liver Cancer via HMGB1-mediated Inactivation of the PI3K/AKT/mTOR Signaling Pathway · Recent Patents on Anti-Cancer Drug Discovery · 2025 · Same journal
• L-Selenomethylselenocysteine Exerts Inhibitory Effects on the Progression of Esophageal Cancer by Targeting the PI3K/AKT Signaling Pathway · Recent Patents on Anti-Cancer Drug Discovery · 2025 · Same journal
• MYH9 Promotes the Proliferation and Progression of Squamous Cervical Cancer Cells · Recent Patents on Anti-Cancer Drug Discovery · 2026 · Same journal
• B-9-8, a Novel Harman Dimer, Reverses ABCG2-mediated Chemotherapeutic Drug Resistance · Recent Patents on Anti-Cancer Drug Discovery · 2025 · Same journal